TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
VRCA

Verrica Pharmaceuticals Inc

Healthcare · Biotechnology

4.60$ +5.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Verrica Pharmaceuticals Inc (VRCA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -18 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow VRCA
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-1.6 -4.6 -18 -27 -30 -28 -19 -39 -61 -18
0.0 0.0 0.0 0.3 0.2 0.5 0.7 0.8 1.3 0.4
0.0 0.1 2.3 3.3 9.8 6.1 5.0 14 7.2 3.3
0.0 0.1 2.3 3.3 11 7.5 6.8 – – –
0.3 -0.2 0.9 -1.7 1.6 -0.5 -1.8 9.9 2.0 -6.3
0.8 0.8 0.8 0.7 1.5 0.9 0.3 0.4 0.0 0.0
-80 -80 -80 26 -3.6 -1.0 54 -0.4 0.0 –
0.5 13 78 0.4 0.5 29 27 – – –
– 34 34 34 34 5.0 -44 44 -2.1 -48
0.5 13 99 0.4 35 34 -17 74 38 1.4
-1.1 8.1 1.6 -1.0 1.4 5.1 19 35 -23 -16
-1.6 -4.6 -19 -28 -32 -28 -19 -39 -61 -18

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?